Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.25
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
6.26
+0.01 (0.16%)
After-hours: Dec 5, 2025, 4:00 PM EST
Kezar Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -61.71 | -83.74 | -101.87 | -68.24 | -54.63 | -41.74 | |
| Depreciation & Amortization | 0.98 | 1.04 | 1.07 | 1.02 | 1.51 | 1.54 | |
| Other Amortization | 0.3 | 0.26 | 0.24 | 0.21 | 0.09 | - | |
| Loss (Gain) From Sale of Assets | -0 | - | - | - | - | - | |
| Asset Writedown & Restructuring Costs | - | 1.55 | 2.91 | - | - | - | |
| Loss (Gain) From Sale of Investments | -2.68 | -5.04 | -6.83 | -1.4 | 1.77 | 0.32 | |
| Stock-Based Compensation | 10.64 | 13.01 | 18.14 | 14.01 | 7.6 | 4.94 | |
| Other Operating Activities | 0.29 | 0.01 | 0 | 0.01 | - | - | |
| Change in Accounts Payable | -8.29 | -3.15 | 6.35 | 1.81 | 1.22 | 0.31 | |
| Change in Other Net Operating Assets | 3.82 | 1.85 | -1.64 | -6.27 | 0.01 | -2.32 | |
| Operating Cash Flow | -56.64 | -74.21 | -81.65 | -58.85 | -42.44 | -36.95 | |
| Capital Expenditures | -0.02 | -0.03 | -1.81 | -1.58 | -0.32 | -0.19 | |
| Sale of Property, Plant & Equipment | 0.01 | - | 0.01 | - | - | - | |
| Investment in Securities | 64.61 | 80.46 | 77.85 | -89.81 | -28.13 | -56.3 | |
| Investing Cash Flow | 64.6 | 80.43 | 76.05 | -91.39 | -28.44 | -56.5 | |
| Long-Term Debt Issued | - | - | - | - | 9.53 | - | |
| Net Debt Issued (Repaid) | -3.91 | - | - | - | 9.53 | - | |
| Issuance of Common Stock | 0.08 | 0.1 | 0.64 | 127.86 | 103.05 | 99.64 | |
| Financing Cash Flow | -3.83 | 0.1 | 0.64 | 127.86 | 112.59 | 99.64 | |
| Foreign Exchange Rate Adjustments | -0.05 | -0.06 | -0 | -0.05 | -0.05 | 0.08 | |
| Net Cash Flow | 4.08 | 6.26 | -4.96 | -22.43 | 41.65 | 6.28 | |
| Free Cash Flow | -56.66 | -74.24 | -83.46 | -60.42 | -42.75 | -37.14 | |
| Free Cash Flow Margin | - | - | -1192.21% | - | - | - | |
| Free Cash Flow Per Share | -7.75 | -10.18 | -11.50 | -8.97 | -8.10 | -8.44 | |
| Cash Interest Paid | 0.99 | 1.34 | 1.32 | 0.97 | 0.07 | - | |
| Levered Free Cash Flow | -34.61 | -45.24 | -39.23 | -36 | -22.7 | -21.69 | |
| Unlevered Free Cash Flow | -33.92 | -44.5 | -38.5 | -35.47 | -22.69 | -21.69 | |
| Change in Working Capital | -4.46 | -1.3 | 4.71 | -4.46 | 1.23 | -2.01 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.